Scott G, Worku D
Health Sci Rep. 2024; 7(9):e70089.
PMID: 39319247
PMC: 11420300.
DOI: 10.1002/hsr2.70089.
Singh M, Leddy S, Iniguez L, Bendall M, Nixon D, Feschotte C
bioRxiv. 2024; .
PMID: 38168352
PMC: 10760019.
DOI: 10.1101/2023.12.11.571123.
Kumari B, Hajela K, Ali A, Sharma A, Yadav R, Ranjan A
Indian J Clin Biochem. 2022; 38(1):102-109.
PMID: 35756690
PMC: 9207170.
DOI: 10.1007/s12291-022-01033-z.
Ahmed R, Adekoya K, Onwuamah C, Oboh B, Iyer S, Oluwatosin A
Viruses. 2022; 14(6).
PMID: 35746741
PMC: 9228396.
DOI: 10.3390/v14061270.
Isnard S, Royston L, Lin J, Fombuena B, Bu S, Kant S
Viruses. 2022; 14(3).
PMID: 35336860
PMC: 8949460.
DOI: 10.3390/v14030453.
Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.
Loucif H, Dagenais-Lussier X, Avizonis D, Choiniere L, Beji C, Cassin L
Autophagy. 2021; 18(6):1256-1273.
PMID: 34612140
PMC: 9225533.
DOI: 10.1080/15548627.2021.1972403.
A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo.
Berg M, Olivo A, Harris B, Rodgers M, James L, Mampunza S
EBioMedicine. 2021; 65:103258.
PMID: 33674212
PMC: 7992073.
DOI: 10.1016/j.ebiom.2021.103258.
Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.
Gomes S, da Silva Graca Amoras E, Gomes E, Queiroz M, Junior E, Mota de Vasconcelos Massafra J
BMC Infect Dis. 2020; 20(1):546.
PMID: 32711474
PMC: 7382849.
DOI: 10.1186/s12879-020-05268-0.
HIV-1 elite controllers: an immunovirological review and clinical perspectives.
Gebara N, El Kamari V, Rizk N
J Virus Erad. 2019; 5(3):163-166.
PMID: 31700663
PMC: 6816117.
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol.
Routy J, Isnard S, Mehraj V, Ostrowski M, Chomont N, Ancuta P
BMJ Open. 2019; 9(4):e028444.
PMID: 31005944
PMC: 6500211.
DOI: 10.1136/bmjopen-2018-028444.
Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors.
Van Hecke C, Trypsteen W, Malatinkova E, De Spiegelaere W, Vervisch K, Rutsaert S
EBioMedicine. 2019; 41:443-454.
PMID: 30770230
PMC: 6442000.
DOI: 10.1016/j.ebiom.2019.02.006.
Sex Differences in HIV Infection.
Scully E
Curr HIV/AIDS Rep. 2018; 15(2):136-146.
PMID: 29504062
PMC: 5882769.
DOI: 10.1007/s11904-018-0383-2.
Case report: mechanisms of HIV elite control in two African women.
Moosa Y, Tanko R, Ramsuran V, Singh R, Madzivhandila M, Yende-Zuma N
BMC Infect Dis. 2018; 18(1):54.
PMID: 29370775
PMC: 5785875.
DOI: 10.1186/s12879-018-2961-8.
HIV as a Cause of Immune Activation and Immunosenescence.
Sokoya T, Steel H, Nieuwoudt M, Rossouw T
Mediators Inflamm. 2017; 2017:6825493.
PMID: 29209103
PMC: 5676471.
DOI: 10.1155/2017/6825493.
Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression.
Wu B, Ouyang Z, Lyon C, Zhang W, Clift T, Bone C
ACS Infect Dis. 2017; 3(12):880-885.
PMID: 28862830
PMC: 5727467.
DOI: 10.1021/acsinfecdis.7b00042.
Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.
Li H, Omange R, Czarnecki C, Correia-Pinto J, Crecente-Campo J, Richmond M
J Med Primatol. 2017; 46(4):137-143.
PMID: 28748659
PMC: 5560087.
DOI: 10.1111/jmp.12300.
Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.
Ouyang Y, Yin Q, Li W, Li Z, Kong D, Wu Y
Sci Rep. 2017; 7(1):6222.
PMID: 28740221
PMC: 5524822.
DOI: 10.1038/s41598-017-05594-5.
Cis-regulatory evolution in a wild primate: Infection-associated genetic variation drives differential expression of MHC-DQA1 in vitro.
Simons N, Eick G, Ruiz-Lopez M, Omeja P, Chapman C, Goldberg T
Mol Ecol. 2017; 26(17):4523-4535.
PMID: 28665019
PMC: 5570663.
DOI: 10.1111/mec.14221.
Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.
Gomes S, Gomes E, Dos Santos M, Lima S, Queiroz M, Machado L
BMC Infect Dis. 2017; 17(1):381.
PMID: 28571570
PMC: 5455094.
DOI: 10.1186/s12879-017-2491-9.
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?.
Vieillard V, Gharakhanian S, Lucar O, Katlama C, Launay O, Autran B
Oncotarget. 2016; 7(25):38946-38958.
PMID: 26950274
PMC: 5122442.
DOI: 10.18632/oncotarget.7793.
